A randomized, double-blind study on the safety and immunogenicity of rTSST-1 variant vaccine: phase 2 results.
Schoergenhofer C, Gelbenegger G, Hasanacevic D, Schöner L, Steiner MM, Firbas C, Buchtele N, Derhaschnig U, Tanzmann A, Model N, Larcher-Senn J, Drost M, Eibl MM, Roetzer A, Jilma B.
Schoergenhofer C, et al. Among authors: steiner mm.
EClinicalMedicine. 2024 Jan 5;67:102404. doi: 10.1016/j.eclinm.2023.102404. eCollection 2024 Jan.
EClinicalMedicine. 2024.
PMID: 38274114
Free PMC article.